These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

268 related items for PubMed ID: 29451818

  • 1. Overexpression of heart-specific small subunit of myosin light chain phosphatase results in heart failure and conduction disturbance.
    Arimura T, Muchir A, Kuwahara M, Morimoto S, Ishikawa T, Du CK, Zhan DY, Nakao S, Machida N, Tanaka R, Yamane Y, Hayashi T, Kimura A.
    Am J Physiol Heart Circ Physiol; 2018 Jun 01; 314(6):H1192-H1202. PubMed ID: 29451818
    [Abstract] [Full Text] [Related]

  • 2. Acute heart failure with cardiomyocyte atrophy induced in adult mice by ablation of cardiac myosin light chain kinase.
    Massengill MT, Ashraf HM, Chowdhury RR, Chrzanowski SM, Kar J, Warren SA, Walter GA, Zeng H, Kang BH, Anderson RH, Moss RL, Kasahara H.
    Cardiovasc Res; 2016 Jul 01; 111(1):34-43. PubMed ID: 27025239
    [Abstract] [Full Text] [Related]

  • 3. Dysfunction of Myosin Light-Chain 4 (MYL4) Leads to Heritable Atrial Cardiomyopathy With Electrical, Contractile, and Structural Components: Evidence From Genetically-Engineered Rats.
    Peng W, Li M, Li H, Tang K, Zhuang J, Zhang J, Xiao J, Jiang H, Li D, Yu Y, Sham PC, Nattel S, Xu Y.
    J Am Heart Assoc; 2017 Oct 28; 6(11):. PubMed ID: 29080865
    [Abstract] [Full Text] [Related]

  • 4. Overexpression of myosin phosphatase reduces Ca(2+) sensitivity of contraction and impairs cardiac function.
    Mizutani H, Okamoto R, Moriki N, Konishi K, Taniguchi M, Fujita S, Dohi K, Onishi K, Suzuki N, Satoh S, Makino N, Itoh T, Hartshorne DJ, Ito M.
    Circ J; 2010 Jan 28; 74(1):120-8. PubMed ID: 19966500
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Hypercontractile mutant of ventricular myosin essential light chain leads to disruption of sarcomeric structure and function and results in restrictive cardiomyopathy in mice.
    Yuan CC, Kazmierczak K, Liang J, Kanashiro-Takeuchi R, Irving TC, Gomes AV, Wang Y, Burghardt TP, Szczesna-Cordary D.
    Cardiovasc Res; 2017 Aug 01; 113(10):1124-1136. PubMed ID: 28371863
    [Abstract] [Full Text] [Related]

  • 8. Restoration of Cardiac Myosin Light Chain Kinase Ameliorates Systolic Dysfunction by Reducing Superrelaxed Myosin.
    Hitsumoto T, Tsukamoto O, Matsuoka K, Li J, Liu L, Kuramoto Y, Higo S, Ogawa S, Fujino N, Yoshida S, Kioka H, Kato H, Hakui H, Saito Y, Okamoto C, Inoue H, Hyejin J, Ueda K, Segawa T, Nishimura S, Asano Y, Asanuma H, Tani A, Imamura R, Komagawa S, Kanai T, Takamura M, Sakata Y, Kitakaze M, Haruta JI, Takashima S.
    Circulation; 2023 Jun 20; 147(25):1902-1918. PubMed ID: 37128901
    [Abstract] [Full Text] [Related]

  • 9. Heart-specific small subunit of myosin light chain phosphatase activates rho-associated kinase and regulates phosphorylation of myosin phosphatase target subunit 1.
    Shichi D, Arimura T, Ishikawa T, Kimura A.
    J Biol Chem; 2010 Oct 29; 285(44):33680-90. PubMed ID: 20801872
    [Abstract] [Full Text] [Related]

  • 10. Impaired Protein Quality Control During Left Ventricular Remodeling in Mice With Cardiac Restricted Overexpression of Tumor Necrosis Factor.
    Hartupee J, Szalai GD, Wang W, Ma X, Diwan A, Mann DL.
    Circ Heart Fail; 2017 Dec 29; 10(12):. PubMed ID: 29203562
    [Abstract] [Full Text] [Related]

  • 11. Prevention of myofilament dysfunction by beta-blocker therapy in postinfarct remodeling.
    Duncker DJ, Boontje NM, Merkus D, Versteilen A, Krysiak J, Mearini G, El-Armouche A, de Beer VJ, Lamers JM, Carrier L, Walker LA, Linke WA, Stienen GJ, van der Velden J.
    Circ Heart Fail; 2009 May 29; 2(3):233-42. PubMed ID: 19808345
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Deletion of obscurin immunoglobulin domains Ig58/59 leads to age-dependent cardiac remodeling and arrhythmia.
    Grogan A, Coleman A, Joca H, Granzier H, Russel MW, Ward CW, Kontrogianni-Konstantopoulos A.
    Basic Res Cardiol; 2020 Sep 10; 115(6):60. PubMed ID: 32910221
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. LKB1 knockout mouse develops spontaneous atrial fibrillation and provides mechanistic insights into human disease process.
    Ozcan C, Battaglia E, Young R, Suzuki G.
    J Am Heart Assoc; 2015 Mar 15; 4(3):e001733. PubMed ID: 25773299
    [Abstract] [Full Text] [Related]

  • 17. Myosin light chain phosphorylation is critical for adaptation to cardiac stress.
    Warren SA, Briggs LE, Zeng H, Chuang J, Chang EI, Terada R, Li M, Swanson MS, Lecker SH, Willis MS, Spinale FG, Maupin-Furlowe J, McMullen JR, Moss RL, Kasahara H.
    Circulation; 2012 Nov 27; 126(22):2575-88. PubMed ID: 23095280
    [Abstract] [Full Text] [Related]

  • 18. Discrete effects of A57G-myosin essential light chain mutation associated with familial hypertrophic cardiomyopathy.
    Kazmierczak K, Paulino EC, Huang W, Muthu P, Liang J, Yuan CC, Rojas AI, Hare JM, Szczesna-Cordary D.
    Am J Physiol Heart Circ Physiol; 2013 Aug 15; 305(4):H575-89. PubMed ID: 23748425
    [Abstract] [Full Text] [Related]

  • 19. Constitutive phosphorylation of cardiac myosin regulatory light chain in vivo.
    Chang AN, Battiprolu PK, Cowley PM, Chen G, Gerard RD, Pinto JR, Hill JA, Baker AJ, Kamm KE, Stull JT.
    J Biol Chem; 2015 Apr 24; 290(17):10703-16. PubMed ID: 25733667
    [Abstract] [Full Text] [Related]

  • 20. Reversibility of adverse, calcineurin-dependent cardiac remodeling.
    Berry JM, Le V, Rotter D, Battiprolu PK, Grinsfelder B, Tannous P, Burchfield JS, Czubryt M, Backs J, Olson EN, Rothermel BA, Hill JA.
    Circ Res; 2011 Aug 05; 109(4):407-17. PubMed ID: 21700928
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.